Blind, Yet Seeing: The Brain’s Subconscious Visual Sense

Researchers have found that those without the sense of sight are still able to "see" with their mind.
Blind, Yet Seeing: The Brain’s Subconscious Visual Sense

#24: Gene Therapy Returns (Some) Sight to (Some) Blind People

For those suffering from Leber’s congenital amaurosis, which causes blindness, a cure seemed like a pipe dream—until scientists tried a new form of gene therapy.
#24: Gene Therapy Returns (Some) Sight to (Some) Blind People

Really?: The Claim: Blind People Do Not See Images in Their Dreams

Do people who don’t see images during the day see them when they shut their eyes at night?
Really?: The Claim: Blind People Do Not See Images in Their Dreams

Diabetes Epidemic Signals an Increase in Blindness, Too

The number of adults suffering a common cause of blindness will triple by 2050, according to a new study.
Diabetes Epidemic Signals an Increase in Blindness, Too

An Ace For Visually-Impaired Students In Computer Science

Many computing luminaries, such as Steve Jobs or Bill Gates, have an early experience in common--an engaging experience in middle school or high school that sparked an excitement for learning everything they could about computers. Today, many young people are surrounded by computing at home and in school, and some of them will likely find a similar passion that will lead them to push tomorrow's frontiers in computer science.
An Ace For Visually-Impaired Students In Computer Science

Global Update: Ivory Coast Threatened With a Resurgence of River Blindness

River blindness is one of a handful of diseases hovering close to eradication but hard to finish off.
Global Update: Ivory Coast Threatened With a Resurgence of River Blindness

Delcath Systems Granted Orphan-Drug Designations For Cutaneous And Ocular Melanoma

Delcath Systems, Inc. (Nasdaq: DCTH), a medical technology company testing its proprietary liver cancer treatment for melanoma metastatic to the liver, announced that the United States Food and Drug Administration ("FDA") granted to Delcath two orphan-drug applications for the drug melphalan. Delcath was granted designations of the drug melphalan for the treatment of patients with cutaneous as well as ocular melanoma.
Delcath Systems Granted Orphan-Drug Designations For Cutaneous And Ocular Melanoma